Levine James E. 4
4 · Cardiff Oncology, Inc. · Filed Sep 13, 2021
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-09-10$6.62/sh+5,000$33,100→ 5,000 total - Purchase
Common Stock
2021-09-10$6.75/sh+5,000$33,750→ 10,000 total - Purchase
Common Stock
2021-09-10$6.38/sh+10,000$63,800→ 20,000 total - Purchase
Common Stock
2021-09-10$6.35/sh+5,000$31,750→ 25,000 total - Purchase
Common Stock
2021-09-10$6.32/sh+5,000$31,600→ 30,000 total